Literature DB >> 16533158

The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress.

Jason D Morrow1.   

Abstract

The isoprostanes (IsoPs) are a series of novel prostaglandin-like compounds formed in vivo in humans from the free radical-catalyzed peroxidation of arachidonate independent of the cyclooxygenase. While quantification of these compounds is a highly accurate measure of oxidant stress in vivo in humans, IsoPs also possess potent biological activity and likely mediate certain aspects of oxidative injury. The purpose of this review is to summarize selected aspects of our knowledge regarding the bioactivity of the IsoPs. I will first briefly highlight mechanisms involved in IsoP formation. Subsequently, I will discuss the biological activities of certain IsoPs that are formed in abundance in vivo and focus on two compounds, 15-F(2t)-IsoP and 15-E(2t)-IsoP, that have been studied in the greatest detail. This review will then examine, at a molecular level, mechanisms by which IsoPs exert their bioactivity. It has been shown that they are ligands for various eicosanoid receptors, in particular, the thromboxane receptor. In addition, I will discuss the controversial evidence that a unique IsoP receptor(s) exists. Finally, I will offer avenues for future research related to the development of pharmacological approaches to modulate IsoP formation and action in vivo and thus decrease the pathophysiological sequelae of oxidative injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533158     DOI: 10.2174/138161206776055985

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  44 in total

1.  F2-isoprostanes and Metabolite, and Breast Cancer Risk.

Authors:  Qi Dai; Xiangzhu Zhu
Journal:  N Am J Med Sci (Boston)       Date:  2009-07

Review 2.  Human biochemistry of the isoprostane pathway.

Authors:  Ginger L Milne; Huiyong Yin; Jason D Morrow
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

Review 3.  Stable-isotope dilution LC–MS for quantitative biomarker analysis.

Authors:  Eugene Ciccimaro; Ian A Blair
Journal:  Bioanalysis       Date:  2010-02       Impact factor: 2.681

Review 4.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

5.  Chronic Intermittent Hypoxia Causes Lipid Peroxidation and Altered Phase 1 Drug Metabolizing Enzymes in the Neonatal Rat Liver.

Authors:  Charles Cai; Jacob V Aranda; Gloria B Valencia; Jiliu Xu; Kay D Beharry
Journal:  React Oxyg Species (Apex)       Date:  2017-05-01

6.  Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.

Authors:  Christopher M Depner; Moises Torres-Gonzalez; Sasmita Tripathy; Ginger Milne; Donald B Jump
Journal:  J Nutr       Date:  2012-06-27       Impact factor: 4.798

7.  Isoprostanes.

Authors:  L Jackson Roberts; Ginger L Milne
Journal:  J Lipid Res       Date:  2008-10-28       Impact factor: 5.922

8.  Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors.

Authors:  Young Hee Rho; Annette Oeser; Cecilia P Chung; Jason D Morrow; C Michael Stein
Journal:  Arch Drug Inf       Date:  2008-07

9.  Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women's Health Study.

Authors:  Qi Dai; Yu-Tang Gao; Xiao-Ou Shu; Gong Yang; Ginger Milne; Qiuyin Cai; Wanqing Wen; Nathaniel Rothman; Hui Cai; Honglan Li; Yongbing Xiang; Wong-Ho Chow; Wei Zheng
Journal:  J Clin Oncol       Date:  2009-04-20       Impact factor: 44.544

10.  Lifelong running reduces oxidative stress and degenerative changes in the testes of mice.

Authors:  Srinivasulu Chigurupati; Tae Gen Son; Dong-Hoon Hyun; Justin D Lathia; Mohamed R Mughal; Jason Savell; Shuan C Li; G P C Nagaraju; Sic L Chan; Thiruma V Arumugam; Mark P Mattson
Journal:  J Endocrinol       Date:  2008-08-13       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.